Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-24 @ 3:35 PM
NCT ID: NCT01285492
Eligibility Criteria: Inclusion Criteria: * Patients with moderate to severe stable COPD (Stage II or Stage III) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines 2008. * Current or ex-smokers who have a smoking history of at least 10 pack years. (Ten pack years are defined as 20 cigarettes a day for 10 years, or 10 cigarettes a day for 20 years etc.) * Patients with post-bronchodilator forced expiratory volume in one second (FEV1) ≥30% and \< 80% of the predicted normal, and post-bronchodilator FEV1/forced vital capacity (FVC) \< 0.7 at Visit 2. Exclusion Criteria: * Pregnant women or nursing mothers or women of child-bearing potential not using an acceptable method of contraception * Patients requiring long term oxygen therapy * Patients who have had a lower respiratory tract infection within 4 weeks prior to Visit 1 * Patients with concomitant pulmonary disease * Patients with a history of asthma * Any patient with history of malignancy of any organ system (including lung cancer), treated or untreated, within the past 5 years * Patients with a history of certain cardiovascular comorbid conditions * Patients with a known history and diagnosis of alpha-1 antitrypsin deficiency * Patients in the active phase of a supervised pulmonary rehabilitation program * Patients contraindicated for treatment with, or having a history of reactions/ hypersensitivity to anticholinergic agents, long and short acting beta-2 agonists, sympathomimetic amines Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers: False
Sex: ALL
Minimum Age: 40 Years
Study: NCT01285492
Study Brief:
Protocol Section: NCT01285492